A clinical trial listing associated with substance P research was updated on November 13, 2026. The trial, registered as NCT05503147 and titled "Sativex and Gentamicin for Optimized Pharmacological Treatment in Older Patients (CanPan)," is listed as Phase 1. Its status has been updated to COMPLETED as of this date. Substance P remains classified as unapproved for research use only, and is not approved for human therapeutic use. The registry entry reflects only the trial's phase and completion status as recorded on ClinicalTrials.gov. No results, outcomes, or efficacy data are included in this update. Readers should not interpret a completed status as an indication of trial findings, safety, or benefit. Details on study design, endpoints, and eventual results, if posted, would appear separately in the trial registry over time. Those interested in the broader context of substance P, including its research classification and general background, can consult the compound overview for additional information.
Substance P-Related Trial NCT05503147 Marked Completed, Phase 1
See the full substance p overview
Source: https://clinicaltrials.gov/study/NCT05503147